PAREXEL Launches IDMP-Focused Software And Service Solution

Solution developed to help biopharmaceutical companies meet emerging regulatory requirements ahead of deadlineLONDON, November 14, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies. LIQUENT InSight® for IDMP™ is the newest module added to PAREXEL’s Regulatory Information Management (RIM) platform. Beginning in 2018, the European Medicines Agency (EMA) will require biopharmaceutical companies to submit data on medicines in accordance... Source: RealWire

Read More